O

Olema

IPO

San Francisco, United States · Founded 2006 · $265.0M raised

Employees
51–200
Founded
2006
Business Model
B2B
Total Funding
$265.0M
Last Round
$180.0M Growth EquitySep 2023
Rounds
4

About

Olema Oncology is a cancer medicines company focused on breast cancer and related oncology needs. The public company develops pharmaceuticals and biotechnology programs spanning drug development, nuclear receptors, and small molecules. Its San Francisco team describes its mission as making an impact on breast cancer and beyond through the development of cancer medicines.

Summary

Olema is a Biotech company based in San Francisco, United States, founded in 2006. It has raised $265.0M in total across 4 rounds, most recently a $180.0M Growth Equity round in Sep 2023. Investors include Vivo Capital and Lightspeed Venture Partners.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Growth EquityGrowth EquitySep 2023
$180.0M

Sign up to see all 5 rounds

Series A through Growth Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Olema on Indexed.vc
<a href="https://indexed.vc/companies/olema"><img src="https://indexed.vc/api/badge/company/olema" alt="Olema on Indexed.vc" width="260" height="76" /></a>